edoc

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries : an observational study

Cain, Lauren E. and Logan, Roger and Robins, James M. and Sterne, Jonathan A. C. and Sabin, Caroline and Bansi, Loveleen and Justice, Amy and Goulet, Joseph and van Sighem, Ard and de Wolf, Frank and Bucher, Heiner C. and von Wyl, Viktor and Esteve, Anna and Casabona, Jordi and del Amo, Julia and Moreno, Santiago and Seng, Remonie and Meyer, Laurence and Perez-Hoyos, Santiago and Muga, Roberto and Lodi, Sara and Lanoy, Emilie and Costagliola, Dominique and Hernan, Miguel A.. (2011) When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries : an observational study. Annals of internal medicine, Vol. 154, H. 8. pp. 509-515.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004734

Downloads: Statistics Overview

Abstract

Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0.350 × 10(9) cells/L initiate combined antiretroviral therapy (cART), but the optimal CD4 cell count at which cART should be initiated remains a matter of debate.
Faculties and Departments:03 Faculty of Medicine > Departement Klinische Forschung > Clinical Epidemiology and Biostatistics CEB > Klinische Epidemiologie (Bucher H)
UniBasel Contributors:Bucher, Heiner C.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:American College of Physicians
ISSN:0003-4819
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:13 Sep 2013 07:59
Deposited On:13 Sep 2013 07:49

Repository Staff Only: item control page